Speaker illustration

Doctor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

Member of:

European Society of Cardiology
Heart Failure Association

My name Is Michal Laufer Perl (MD, MHA) and I'm the director of the cardio-vascular clinics and practicing in Heart Failure and Cardio-oncology in Tel Aviv Sourasky Medical Center in Israel. I've established the cardio-oncology clinic in our facility in 2016 which today is the largest clinic in Israel with 1300 visits per year. As part of the cardio-oncology clinic we established a prospective registry (ICOR) evaluating all the patients referred to the cardio-oncology clinics and counting for over 600 patients with a number of studies already published and presented in international conferences.

High neutrophil-to-lymphocyte ratio as an early sign for cardiotoxicity in breast cancer patients treated with anthracycline

Event: Heart Failure 2022

Topic: Cardio-Oncology

Session: Heart Failure ePosters - focus on Comorbidities and special population

Thumbnail

Right ventricle strain changes in patients with breast cancer during anthracycline therapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Repetitive milrinone therapy in ambulatory advanced heart failure patients

Event: Heart Failure 2021 Online Congress

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: ePoster session

Thumbnail

Cardio-toxicity among sarcoma patients: a cardio-oncology registry

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Cardio-Oncology

Session: Basic Science

Thumbnail

Longitudinal Diastolic strain as predictor for systolic dysfunction among active breast cancer patients

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Cardio-Oncology

Session: Rapid Fire 6 - Risk stratification and prognosis

Thumbnail

Usefulness of global longitudinal strain as predictor for sub-clinical left ventricular dysfunction and all-cause mortality among active cancer patients

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations

Thumbnail

Routine use of global longitudinal strain among active breast cancer patients: A Cardio-Oncology registry

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Cancer therapeutic related cardiac dysfunction among active breast cancer patients: A Cardio-Oncology registry

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Routine use of global longitudinal strain for early identification of subclinical left ventricular dysfunction among cancer patients: A Cardio-Oncology registry

Event: EuroEcho-Imaging 2017

Topic: Clinical applications

Session: Tissue Doppler and speckle tracking

Thumbnail

Routine use of global longitudinal strain for early identification of subclinical left ventricular dysfunction among cancer patients

Event: ESC CONGRESS 2017

Topic: Cardiotoxicity of drugs

Session: Chronic heart failure (CHF)

Thumbnail

This platform is supported by

logo Novo Nordisk